by admin_prosemble | 2nd December 2024 | News
Prosemble is pleased to announce the successful completion of its angel investor funding round. This milestone marks a significant step forward in advancing our mission to revolutionise precision therapies.
by admin_prosemble | 9th November 2024 | Research, Uncategorized
The cytoskeleton is vital for cell organisation and movement. While eukaryotic actin forms conserved double-stranded filaments, bacterial actins drive key functions and exhibit diverse architectures. We identify a novel actin family in Verrucomicrobiota, forming...
by admin_prosemble | 29th October 2024 | News
Iryna Peretiazhko, a contributor to Prosemble’s creation, published a study on the Tad pilus, revealing how the RcpC-RcpA complex drives pilus assembly and cell-cell aggregation in Pseudomonas aeruginosa. Currently at Imperial College London and the Francis...
by admin_prosemble | 30th August 2024 | News, Research
Exciting news! Our article on Prosemble has been featured in the August edition of AI Spy magazine—check it out! https://heyzine.com/flip-book/fae2b1a0e7.html#page/28
by admin_prosemble | 11th July 2024 | News
Prosemble is thrilled to announce its selection for the prestigious King’s College Spinout Accelerator at King’s Entrepreneurship Institute. This milestone reinforces our mission to drive innovation in AI-powered drug development. Excited for the journey ahead! Meet...
